A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 595-595
◽
2018 ◽
Vol 46
(2)
◽
pp. 626-636
2022 ◽
Vol 19
(2)
◽
pp. 759
2017 ◽
Vol 96
◽
pp. 74-79
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 712-712
◽